SEHK:1548Life Sciences
GenScript Biotech Links AI Drug Discovery Push With Discounted Valuation
GenScript Biotech (SEHK:1548) recently hosted a major global forum focused on practical applications of artificial intelligence in biopharma and drug discovery.
The company is also working with Latent Labs as a wet lab partner to rapidly test and validate AI generated molecules for potential therapeutics.
For you as an investor or industry follower, this update highlights how GenScript Biotech is positioning itself at the intersection of AI tools and biopharma research. The company is known...